DGX — Quest Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00- $21.19bn
- $26.66bn
- $9.87bn
- 95
- 54
- 82
- 92
Annual cashflow statement for Quest Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,499 | 2,080 | 1,015 | 908 | 921 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 38 | -285 | 146 | 119 | 108 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 22 | 87 | 119 | -145 | -201 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 2,005 | 2,233 | 1,718 | 1,272 | 1,334 |
| Capital Expenditures | -418 | -403 | -404 | -408 | -425 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -354 | 424 | -139 | -653 | -2,123 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -772 | 21 | -543 | -1,061 | -2,548 |
| Financing Cash Flow Items | -29 | -159 | -140 | -71 | -50 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,267 | -2,540 | -1,732 | 160 | 1,084 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -34 | -286 | -557 | 371 | -137 |